Question 1

What are the expected benefits of participating in this trial compared to standard treatments?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Neoadjuvant Trial of Capecitabine for Axillary Lymph Node Positive Operable Breast Cancer clinical trial (NCT02115152). Contact the study team or your healthcare provider for specific answers.

Question 2

How will this treatment affect my overall health and daily life?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Neoadjuvant Trial of Capecitabine for Axillary Lymph Node Positive Operable Breast Cancer clinical trial (NCT02115152). Contact the study team or your healthcare provider for specific answers.

Question 3

What side effects should I be aware of with these medications?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Neoadjuvant Trial of Capecitabine for Axillary Lymph Node Positive Operable Breast Cancer clinical trial (NCT02115152). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to come in for treatments and check-ups?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Neoadjuvant Trial of Capecitabine for Axillary Lymph Node Positive Operable Breast Cancer clinical trial (NCT02115152). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects or complications during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Neoadjuvant Trial of Capecitabine for Axillary Lymph Node Positive Operable Breast Cancer clinical trial (NCT02115152). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any other treatment options I should consider alongside this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Neoadjuvant Trial of Capecitabine for Axillary Lymph Node Positive Operable Breast Cancer clinical trial (NCT02115152). Contact the study team or your healthcare provider for specific answers.

What this study is about